['Autophagy', 'Chaperone Mediated Autophagy', 'Macroautophagy', 'Selective autophagy', 'Mitophagy', 'Pink/Parkin Mediated Mitophagy', 'Receptor Mediated Mitophagy', 'Lipophagy', 'Aggrephagy', 'Late endosomal microautophagy', 'Cell Cycle', 'Cell Cycle Checkpoints', 'Mitotic Spindle Checkpoint', 'Amplification of signal from the kinetochores', 'Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal', 'Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components', 'Inactivation of APC/C via direct inhibition of the APC/C complex', 'G2/M Checkpoints', 'G2/M DNA damage checkpoint', 'Removal of the Flap Intermediate from the C-strand', 'Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex', 'MAPK3 (ERK1) activation', 'MAPK1 (ERK2) activation', 'RAF-independent MAPK1/3 activation', 'G2/M DNA replication checkpoint', 'Activation of ATR in response to replication stress', 'G2 Phase', 'Transcriptional  activation of  cell cycle inhibitor p21 ', 'Transcriptional activation of p53 responsive genes  ', 'Autodegradation of the E3 ubiquitin ligase COP1', 'Stabilization of p53', 'SCF(Skp2)-mediated degradation of p27/p21', 'Cyclin A:Cdk2-associated events at S phase entry', 'CDT1 association with the CDC6:ORC:origin complex', 'CDC6 association with the ORC:origin complex', 'Activation of the pre-replicative complex', 'Assembly of the ORC complex at the origin of replication', 'Assembly of the pre-replicative complex', 'DNA replication initiation', 'CDK-mediated phosphorylation and removal of Cdc6', 'Orc1 removal from chromatin', 'Switching of origins to a post-replicative state', 'Polymerase switching', 'Leading Strand Synthesis', 'Unwinding of DNA', 'Removal of the Flap Intermediate', 'Processive synthesis on the lagging strand', 'Lagging Strand Synthesis', 'DNA strand elongation', 'Inhibition of replication initiation of damaged DNA by RB1/E2F1', 'E2F mediated regulation of DNA replication', 'E2F-enabled inhibition of pre-replication complex formation', 'Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes', 'Cyclin E associated events during G1/S transition ', 'G1/S Transition', 'G1/S-Specific Transcription', 'Cyclin D associated events in G1', 'G1 Phase', 'Synthesis of DNA', 'Ubiquitin-dependent degradation of Cyclin D', 'Establishment of Sister Chromatid Cohesion', 'Recruitment of NuMA to mitotic centrosomes', 'EML4 and NUDC in mitotic spindle formation', 'Condensation of Prometaphase Chromosomes', 'Resolution of Sister Chromatid Cohesion', 'MASTL Facilitates Mitotic Progression', 'Activation of NIMA Kinases NEK9, NEK6, NEK7', 'Nuclear Pore Complex (NPC) Disassembly', 'Depolymerisation of the Nuclear Lamina', 'Nuclear Envelope Breakdown', 'Condensation of Prophase Chromosomes', 'Golgi Cisternae Pericentriolar Stack Reorganization', 'FBXL7 down-regulates AURKA during mitotic entry and in early mitosis', 'Interaction between PHLDA1 and AURKA', 'Cyclin A/B1/B2 associated events during G2/M transition', 'Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes', 'AURKA Activation by TPX2', 'Polo-like kinase mediated events', 'Recruitment of mitotic centrosome proteins and complexes', 'Loss of Nlp from mitotic centrosomes', 'Loss of proteins required for interphase microtubule organization from the centrosome', 'Centrosome maturation', 'The role of GTSE1 in G2/M progression after G2 checkpoint', 'Regulation of PLK1 Activity at G2/M Transition', 'G2/M Transition', 'Mitotic Metaphase/Anaphase Transition', 'Separation of Sister Chromatids', 'Initiation of Nuclear Envelope Reformation', 'Nuclear Envelope Reassembly', 'Mitotic Anaphase', 'Mitotic Metaphase and Anaphase', 'Mitotic Prometaphase', 'Mitotic Prophase', 'Mitotic G2-G2/M phases', 'Transcriptional Regulation by TP53', 'TP53 Regulates Metabolic Genes', 'Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.', 'Respiratory electron transport', 'Complex I biogenesis', 'Formation of ATP by chemiosmotic coupling', 'The fatty acid cycling model', 'The proton buffering model', 'Mitochondrial Uncoupling Proteins', 'Synthesis of Ketone Bodies', 'Utilization of Ketone Bodies', 'Ketone body metabolism', 'mitochondrial fatty acid beta-oxidation of unsaturated fatty acids', 'Beta oxidation of octanoyl-CoA to hexanoyl-CoA', 'Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA', 'Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA', 'Beta oxidation of myristoyl-CoA to lauroyl-CoA', 'Beta oxidation of palmitoyl-CoA to myristoyl-CoA', 'Beta oxidation of hexanoyl-CoA to butanoyl-CoA', 'Beta oxidation of butanoyl-CoA to acetyl-CoA', 'mitochondrial fatty acid beta-oxidation of saturated fatty acids', 'Propionyl-CoA catabolism', 'Mitochondrial Fatty Acid Beta-Oxidation', 'PIP3 activates AKT signaling', 'AKT phosphorylates targets in the nucleus', 'AKT phosphorylates targets in the cytosol', 'Negative regulation of the PI3K/AKT network', 'PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling', 'PTEN Regulation', 'Regulation of PTEN mRNA translation', 'Competing endogenous RNAs (ceRNAs) regulate PTEN translation', 'Regulation of PTEN localization', 'Regulation of PTEN gene transcription', 'Regulation of PTEN stability and activity', 'Downstream signal transduction', 'CaMK IV-mediated phosphorylation of CREB', 'PKA activation', 'PKA-mediated phosphorylation of CREB', 'Cam-PDE 1 activation', 'Calmodulin induced events', 'CaM pathway', 'DAG and IP3 signaling', 'MAP2K and MAPK activation', 'Negative feedback regulation of MAPK pathway', 'Negative regulation of MAPK pathway', 'RAF activation', 'Regulation of RAS by GAPs', 'SHC-mediated cascade:FGFR3', 'PI-3K cascade:FGFR3', 'Phospholipase C-mediated cascade; FGFR3', 'FRS-mediated FGFR3 signaling', 'Downstream signaling of activated FGFR3', 'Spry regulation of FGF signaling', 'Negative regulation of FGFR3 signaling', 'FGFR3b ligand binding and activation', 'FGFR3c ligand binding and activation', 'FGFR3 ligand binding and activation', 'Signaling by FGFR3', 'RAF/MAP kinase cascade', 'Signaling by ERBB2', 'GRB2 events in ERBB2 signaling', 'SHC1 events in ERBB2 signaling', 'PI3K events in ERBB2 signaling', 'Drug-mediated inhibition of ERBB2 signaling', 'PLCG1 events in ERBB2 signaling', 'Downregulation of ERBB2 signaling', 'Downregulation of ERBB2:ERBB3 signaling', 'GRB7 events in ERBB2 signaling', 'ERBB2 Regulates Cell Motility', 'ERBB2 Activates PTK6 Signaling', 'Signaling by PTK6', 'PTK6 Activates STAT3', 'PTK6 promotes HIF1A stabilization', 'PTK6 Expression', 'PTK6 Down-Regulation', 'PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases', 'PTK6 Regulates Cell Cycle', 'PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1', 'PTK6 Regulates Proteins Involved in RNA Processing', 'RHO GTPases Activate Formins', 'Integrin cell surface interactions', 'Beta-catenin independent WNT signaling', 'Ca2+ pathway', 'PCP/CE pathway', 'Asymmetric localization of PCP proteins', 'WNT5A-dependent internalization of FZD2, FZD5 and ROR2', 'WNT5A-dependent internalization of FZD4', 'TCF dependent signaling in response to WNT', 'Deactivation of the beta-catenin transactivating complex', 'Negative regulation of TCF-dependent signaling by DVL-interacting proteins', 'Disassembly of the destruction complex and recruitment of AXIN to the membrane', 'Regulation of FZD by ubiquitination', 'Degradation of DVL', 'Degradation of AXIN', 'Negative regulation of TCF-dependent signaling by WNT ligand antagonists', 'Formation of the beta-catenin:TCF transactivating complex', 'Binding of TCF/LEF:CTNNB1 to target gene promoters', 'WNT mediated activation of DVL', 'Degradation of beta-catenin by the destruction complex', 'Beta-catenin phosphorylation cascade', 'Repression of WNT target genes', 'WNT ligand biogenesis and trafficking', 'Cell junction organization', 'Cell-cell junction organization', 'Adherens junctions interactions', 'Nectin/Necl  trans heterodimerization', 'SDK interactions', 'Tight junction interactions', 'Cell-extracellular matrix interactions', 'Localization of the PINCH-ILK-PARVIN complex to focal adhesions', 'Regulation of cytoskeletal remodeling and cell spreading by IPP complex components', 'Type I hemidesmosome assembly', 'RHO GTPases activate PAKs', 'Fcgamma receptor (FCGR) dependent phagocytosis', 'Role of phospholipids in phagocytosis', 'Regulation of actin dynamics for phagocytic cup formation', 'FCGR activation', 'RHO GTPases Activate ROCKs', 'Semaphorin interactions', 'CRMPs in Sema3A signaling', 'Sema3A PAK dependent Axon repulsion', 'SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion', 'Other semaphorin interactions', 'Sema4D in semaphorin signaling', 'Sema4D mediated inhibition of cell attachment and migration', 'Sema4D induced cell migration and growth-cone collapse', 'RHO GTPases activate KTN1', 'Signaling by EGFR', 'SHC1 events in EGFR signaling', 'GRB2 events in EGFR signaling', 'GAB1 signalosome', 'EGFR downregulation', 'EGFR interacts with phospholipase C-gamma', 'Nuclear signaling by ERBB4', 'PI3K events in ERBB4 signaling', 'SHC1 events in ERBB4 signaling', 'Downregulation of ERBB4 signaling', 'Activation of RAC1 downstream of NMDARs', 'Long-term potentiation', 'CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde', 'RSK activation', 'CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling', 'Ras activation upon Ca2+ influx through NMDA receptor', 'CREB1 phosphorylation through the activation of Adenylate Cyclase', 'Post NMDA receptor activation events', 'Activation of AMPK downstream of NMDARs', 'Unblocking of NMDA receptors, glutamate binding and activation', 'Assembly and cell surface presentation of NMDA receptors', 'Activation of NMDA receptors and postsynaptic events', 'Negative regulation of NMDA receptor-mediated neuronal transmission', 'Glutamate binding, activation of AMPA receptors and synaptic plasticity', 'Trafficking of AMPA receptors', 'Trafficking of GluR2-containing AMPA receptors', 'Activation of AMPA receptors', 'DAP12 signaling', 'Phosphorylation of CD3 and TCR zeta chains', 'Translocation of ZAP-70 to Immunological synapse', 'Generation of second messenger molecules', 'Downstream TCR signaling', 'TCR signaling', 'MET activates RAS signaling', 'MET Receptor Activation', 'MET activates PTPN11', 'MET activates RAP1 and RAC1', 'MET interacts with TNS proteins', 'MET activates PTK2 signaling', 'MET promotes cell motility', 'MET activates STAT3', 'Negative regulation of MET activity', 'MET activates PI3K/AKT signaling', 'MET receptor recycling', 'Signaling by MET', 'Estrogen-dependent nuclear events downstream of ESR-membrane signaling', 'Estrogen-stimulated signaling through PRKCZ', 'eNOS activation', 'NOSTRIN mediated eNOS trafficking', 'NADPH regeneration', 'Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation', 'Ubiquinol biosynthesis', 'Metabolism of cofactors', 'Metabolism of nitric oxide: eNOS activation and regulation', 'NOSIP mediated eNOS trafficking', 'PD-1 signaling', 'CD28 dependent PI3K/Akt signaling', 'CD28 dependent Vav1 pathway', 'CD28 co-stimulation', 'CTLA4 inhibitory signaling', 'Costimulation by the CD28 family', 'Regulation of KIT signaling', 'FCERI mediated Ca+2 mobilization', 'Role of LAT2/NTAL/LAB on calcium mobilization', 'FCERI mediated NF-kB activation', 'FCERI mediated MAPK activation', 'Fc epsilon receptor (FCERI) signaling', 'G0 and Early G1', 'Transcription of E2F targets under negative control by DREAM complex', 'Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1', 'SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription', 'Downregulation of SMAD2/3:SMAD4 transcriptional activity', 'TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)', 'Downregulation of TGF-beta receptor signaling', 'TGF-beta receptor signaling activates SMADs', 'Signaling by TGF-beta Receptor Complex', 'Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer', 'Regulation of gene expression by Hypoxia-inducible Factor', 'Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha', 'Cellular response to hypoxia', 'Cohesin Loading onto Chromatin', 'Mitotic Telophase/Cytokinesis', 'S Phase', 'Resolution of D-loop Structures through Holliday Junction Intermediates', 'Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)', 'Resolution of D-Loop Structures', 'Presynaptic phase of homologous DNA pairing and strand exchange', 'Homologous DNA Pairing and Strand Exchange', 'HDR through Homologous Recombination (HRR)', 'Processing of DNA double-strand break ends', 'HDR through Single Strand Annealing (SSA)', 'Sensing of DNA Double Strand Breaks', 'Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks', 'HDR through MMEJ (alt-NHEJ)', 'DNA Double Strand Break Response', 'Nonhomologous End-Joining (NHEJ)', 'HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)', 'Homology Directed Repair', 'DNA Double-Strand Break Repair', 'Formation of TC-NER Pre-Incision Complex', 'Dual incision in TC-NER', 'Gap-filling DNA repair synthesis and ligation in TC-NER', 'Transcription-Coupled Nucleotide Excision Repair (TC-NER)', 'Gap-filling DNA repair synthesis and ligation in GG-NER', 'Dual Incision in GG-NER', 'Formation of Incision Complex in GG-NER', 'DNA Damage Recognition in GG-NER', 'Global Genome Nucleotide Excision Repair (GG-NER)', 'Nucleotide Excision Repair', 'Fanconi Anemia Pathway', 'Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)', 'Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)', 'Mismatch Repair', 'TP53 Regulates Transcription of DNA Repair Genes', 'PI5P Regulates TP53 Acetylation', 'Regulation of TP53 Activity through Acetylation', 'Regulation of TP53 Activity through Methylation', 'Formation of Senescence-Associated Heterochromatin Foci (SAHF)', 'p53-Dependent G1 DNA Damage Response', 'p53-Dependent G1/S DNA damage checkpoint', 'Ubiquitin Mediated Degradation of Phosphorylated Cdc25A', 'p53-Independent DNA Damage Response', 'p53-Independent G1/S DNA damage checkpoint', 'G1/S DNA Damage Checkpoints', 'Activation, translocation and oligomerization of BAX', 'Activation of BAD and translocation to mitochondria ', 'Activation of BMF and translocation to mitochondria', 'Activation of BIM and translocation to mitochondria ', 'Activation of NOXA and translocation to mitochondria', 'Activation of BH3-only proteins', 'Activation of PUMA and translocation to mitochondria', 'Release of apoptotic factors from the mitochondria', 'Regulation of the apoptosome activity', 'Formation of apoptosome', 'Cytochrome c-mediated apoptotic response', 'Activation of caspases through apoptosome-mediated cleavage', 'SMAC (DIABLO) binds to IAPs ', 'SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ', 'SMAC, XIAP-regulated apoptotic response', 'Apoptotic factor-mediated response', 'BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members', 'Activation and oligomerization of BAK protein', 'Activation, myristolyation of BID and translocation to mitochondria', 'Intrinsic Pathway for Apoptosis', 'Pyrimidine biosynthesis', 'Purine ribonucleoside monophosphate biosynthesis', 'Nucleobase biosynthesis', 'Phosphate bond hydrolysis by NUDT proteins', 'Purine catabolism', 'Phosphate bond hydrolysis by NTPDase proteins', 'Pyrimidine catabolism', 'Nucleobase catabolism', 'Purine salvage', 'Pyrimidine salvage', 'Nucleotide salvage', 'Interconversion of nucleotide di- and triphosphates', 'Metabolism of nucleotides', 'Aspartate and asparagine metabolism', 'Cysteine formation from homocysteine', 'Sulfide oxidation to sulfate', 'Degradation of cysteine and homocysteine', 'Methionine salvage pathway', 'Sulfur amino acid metabolism', 'Urea cycle', 'Alanine metabolism', 'Creatine metabolism', 'Lysine catabolism', 'Metabolism of ingested MeSeO2H into MeSeH', 'Metabolism of ingested SeMet, Sec, MeSec into H2Se', 'Selenocysteine synthesis', 'Selenoamino acid metabolism', 'Metabolism of ingested H2SeO4 and H2SeO3 into H2Se', 'Formation of selenosugars for excretion', 'Methylation of MeSeH for excretion', 'Carnitine synthesis', 'Histidine catabolism', 'Nicotinamide salvaging', 'Nicotinate metabolism', 'Tryptophan catabolism', 'Branched-chain amino acid catabolism', 'Phenylalanine metabolism', 'Tyrosine catabolism', 'Phenylalanine and tyrosine metabolism', 'Glycine degradation', 'Glyoxylate metabolism and glycine degradation', 'Regulation of ornithine decarboxylase (ODC)', 'Interconversion of polyamines', 'Agmatine biosynthesis', 'Metabolism of polyamines', 'Proline catabolism', 'Threonine catabolism', 'Choline catabolism', 'Serine biosynthesis', 'Melanin biosynthesis', 'Catecholamine biosynthesis', 'Regulation of thyroid hormone activity', 'Thyroxine biosynthesis', 'Serotonin and melatonin biosynthesis', 'Metabolism of amine-derived hormones', 'Glutamate and glutamine metabolism', 'Metabolism of amino acids and derivatives', '5-Phosphoribose 1-diphosphate biosynthesis', 'Pentose phosphate pathway', 'Glycogen breakdown (glycogenolysis)', 'Glycogen synthesis', 'Glycogen metabolism', 'Lactose synthesis', 'Galactose catabolism', 'Fructose biosynthesis', 'Fructose catabolism', 'Fructose metabolism', 'Synthesis of dolichyl-phosphate-glucose', 'Synthesis of GDP-mannose', 'Synthesis of UDP-N-acetyl-glucosamine', 'Synthesis of dolichyl-phosphate mannose', 'Sialic acid metabolism', 'GDP-fucose biosynthesis', 'Synthesis of Dolichyl-phosphate', 'Synthesis of substrates in N-glycan biosythesis', 'Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein', 'ER Quality Control Compartment (ERQC)', 'Calnexin/calreticulin cycle', 'N-glycan trimming in the ER and Calnexin/Calreticulin cycle', 'Cargo concentration in the ER', 'COPII-mediated vesicle transport', 'COPI-mediated anterograde transport', 'ER to Golgi Anterograde Transport', 'Reactions specific to the complex N-glycan synthesis pathway', 'Reactions specific to the hybrid N-glycan synthesis pathway', 'N-Glycan antennae elongation', 'N-glycan antennae elongation in the medial/trans-Golgi', 'Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2', 'N-glycan trimming and elongation in the cis-Golgi', 'Transport to the Golgi and subsequent modification', 'A tetrasaccharide linker sequence is required for GAG synthesis', 'HS-GAG degradation', 'HS-GAG biosynthesis', 'Heparan sulfate/heparin (HS-GAG) metabolism', 'Hyaluronan uptake and degradation', 'Hyaluronan biosynthesis and export', 'Hyaluronan metabolism', 'Transport and synthesis of PAPS', 'Keratan sulfate degradation', 'Keratan sulfate biosynthesis', 'Keratan sulfate/keratin metabolism', 'CS/DS degradation', 'Chondroitin sulfate biosynthesis', 'Dermatan sulfate biosynthesis', 'Chondroitin sulfate/dermatan sulfate metabolism', 'Glycosaminoglycan metabolism', 'Asparagine N-linked glycosylation', 'Lysosomal oligosaccharide catabolism', 'Formation of xylulose-5-phosphate', 'Gluconeogenesis', 'Regulation of Glucokinase by Glucokinase Regulatory Protein', 'Regulation of glycolysis by fructose 2,6-bisphosphate metabolism', 'Glycolysis', 'Glucose metabolism', 'ABO blood group biosynthesis', 'Lewis blood group biosynthesis', 'Blood group systems biosynthesis', 'Rhesus blood group biosynthesis', 'Metabolism of carbohydrates', 'Energy dependent regulation of mTOR by LKB1-AMPK', 'Detoxification of Reactive Oxygen Species', 'TP53 Regulates Transcription of Caspase Activators and Caspases', 'TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain', 'TP53 Regulates Transcription of Genes Involved in Cytochrome C Release', 'Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)', 'LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production', 'RIP-mediated NFkB activation via ZBP1', 'IRF3 mediated activation of type 1 IFN', 'ZBP1(DAI) mediated induction of type I IFNs', 'Regulation of innate immune responses to cytosolic DNA', 'Regulation by TREX1', 'STAT6-mediated induction of chemokines', 'IRF3-mediated induction of type I IFN', 'STING mediated induction of host immune responses', 'DEx/H-box helicases activate type I IFN and inflammatory cytokines production ', 'TRAF6 mediated IRF7 activation', 'Negative regulators of DDX58/IFIH1 signaling', 'TRAF3-dependent IRF activation pathway', 'TRAF6 mediated NF-kB activation', 'DDX58/IFIH1-mediated induction of interferon-alpha/beta', 'NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10', 'Cytosolic sensors of pathogen-associated DNA ', 'Events associated with phagocytolytic activity of PMN cells', 'ROS and RNS production in phagocytes', 'Latent infection - Other responses of Mtb to phagocytosis', 'Tolerance of reactive oxygen produced by macrophages', 'Mtb iron assimilation by chelation', 'Tolerance by Mtb to nitric oxide produced by macrophages', 'Cell redox homeostasis', 'RHO GTPases Activate NADPH Oxidases', 'Signaling by VEGF', 'Neurophilin interactions with VEGF and VEGFR', 'VEGFA-VEGFR2 Pathway', 'VEGFR2 mediated cell proliferation', 'VEGFR2 mediated vascular permeability', 'VEGF ligand-receptor interactions', 'VEGF binds to VEGFR leading to receptor dimerization', 'Regulation of RUNX2 expression and activity', 'RUNX2 regulates osteoblast differentiation', 'RUNX2 regulates bone development', 'RUNX2 regulates chondrocyte maturation', 'Activated NOTCH1 Transmits Signal to the Nucleus', 'NOTCH1 Intracellular Domain Regulates Transcription', 'Pre-NOTCH Processing in Golgi', 'Pre-NOTCH Transcription and Translation', 'NOTCH2 Activation and Transmission of Signal to the Nucleus', 'NOTCH2 intracellular domain regulates transcription', 'Signaling by NOTCH2', 'Signaling by NOTCH1', 'Mitotic G1 phase and G1/S transition', 'Oncogene Induced Senescence', 'DNA Damage/Telomere Stress Induced Senescence', 'Senescence-Associated Secretory Phenotype (SASP)', 'Interleukin-6 family signaling', 'Interleukin-6 signaling', 'IL-6-type cytokine receptor ligand interactions', 'Oncogenic MAPK signaling', 'Signaling by RAS mutants', 'RAS GTPase cycle mutants', 'Signaling downstream of RAS mutants', 'Signaling by high-kinase activity BRAF mutants', 'Signaling by moderate kinase activity BRAF mutants', 'Paradoxical activation of RAF signaling by kinase inactive BRAF', 'RAS signaling downstream of NF1 loss-of-function variants', 'Signaling by BRAF and RAF fusions', 'Interleukin-1 family signaling', 'Interleukin-33 signaling', 'Interleukin-37 signaling', 'Interleukin-36 pathway', 'Interleukin-1 processing', 'Interleukin-1 signaling', 'TAK1 activates NFkB by phosphorylation and activation of IKKs complex', 'MAP3K8 (TPL2)-dependent MAPK1/3 activation', 'Interleukin-18 signaling', 'Interleukin-38 signaling', 'Oxidative Stress Induced Senescence', 'Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3', 'RHO GTPases activate PKNs', 'RHO GTPases activate CIT', 'TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest', 'TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest', 'TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain', 'Regulation of TP53 Degradation', 'Regulation of TP53 Activity through Phosphorylation', 'Regulation of TP53 Expression and Degradation', 'Regulation of TP53 Expression', 'RHO GTPases activate IQGAPs', 'RHO GTPases Activate WASPs and WAVEs', 'TP53 Regulates Transcription of Death Receptors and Ligands', 'Deadenylation of mRNA', "mRNA decay by 3' to 5' exoribonuclease", "mRNA decay by 5' to 3' exoribonuclease", 'Deadenylation-dependent mRNA decay', 'TP53 Regulates Transcription of Cell Cycle Genes', 'TP53 Regulates Transcription of Cell Death Genes', 'Apoptotic execution phase', 'Apoptosis induced DNA fragmentation', 'Apoptotic cleavage of cellular proteins', 'Caspase-mediated cleavage of cytoskeletal proteins', 'Apoptotic cleavage of cell adhesion  proteins', 'Breakdown of the nuclear lamina', 'Stimulation of the cell death response by PAK-2p34', 'FasL/ CD95L signaling', 'Caspase activation via Death Receptors in the presence of ligand', 'Regulation by c-FLIP', 'Dimerization of procaspase-8', 'MyD88-independent TLR4 cascade ', 'TRIF(TICAM1)-mediated TLR4 signaling ', 'MAP kinase activation', 'JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1', 'activated TAK1 mediates p38 MAPK activation', 'MAPK targets/ Nuclear events mediated by MAP kinases', 'ERK/MAPK targets', 'ERKs are inactivated', 'CREB phosphorylation', 'Activation of the AP-1 family of transcription factors', 'TRIF-mediated programmed cell death', 'Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon', 'TRAF6-mediated induction of TAK1 complex within TLR4 complex', 'IKK complex recruitment mediated by RIP1', 'Regulated Necrosis', 'RIPK1-mediated regulated necrosis', 'Regulation of necroptotic cell death', 'CASP8 activity is inhibited', 'Apoptosis', 'Regulation of Apoptosis', 'Regulation of PAK-2p34 activity by PS-GAP/RHG10', 'Regulation of activated PAK-2p34 by proteasome mediated degradation', 'Caspase activation via extrinsic apoptotic signalling pathway', 'Caspase activation via Dependence Receptors in the absence of ligand', 'TNF signaling', 'Regulation of TNFR1 signaling', 'TNFR1-induced NFkappaB signaling pathway', 'TNFR1-mediated ceramide production', 'TNFR1-induced proapoptotic signaling', 'Regulated proteolysis of p75NTR', 'NF-kB is activated and signals survival', 'p75NTR recruits signalling complexes', 'p75NTR signals via NF-kB', 'NRAGE signals death through JNK', 'NRIF signals cell death from the nucleus', 'NADE modulates death signalling', 'Cell death signalling via NRAGE, NRIF and NADE', 'NFG and proNGF binds to p75NTR', 'Axonal growth stimulation', 'Axonal growth inhibition (RHOA activation)', 'p75NTR regulates axonogenesis', 'p38MAPK events', 'Signalling to RAS', 'Frs2-mediated activation', 'ARMS-mediated activation', 'Prolonged ERK activation events', 'Signalling to ERKs', 'Signalling to p38 via RIT and RIN', 'Nuclear Events (kinase and transcription factor activation)', 'Signalling to ERK5', 'Retrograde neurotrophin signalling', 'PI3K/AKT activation', 'TRKA activation by NGF', 'Activation of TRKA receptors', 'NGF-independant TRKA activation', 'Signaling by NTRK1 (TRKA)', 'Signalling to STAT3', 'PLC-gamma1 signalling', 'NGF processing', 'p75 NTR receptor-mediated signalling', 'Ceramide signalling', 'p75NTR negatively regulates cell cycle via SC1', 'Basigin interactions', 'Tie2 Signaling', 'Cell surface interactions at the vascular wall', 'PECAM1 interactions', 'Antigen activates B Cell Receptor (BCR) leading to generation of second messengers', 'Activation of RAS in B cells', 'Activation of NF-kappaB in B cells', 'Downstream signaling events of B Cell Receptor (BCR)', 'Calcineurin activates NFAT', 'Transferrin endocytosis and recycling', 'Iron uptake and transport', 'Death Receptor Signalling', 'TRAIL  signaling', 'FRS-mediated FGFR4 signaling', 'SHC-mediated cascade:FGFR4', 'Phospholipase C-mediated cascade; FGFR4', 'PI-3K cascade:FGFR4', 'Downstream signaling of activated FGFR4', 'Negative regulation of FGFR4 signaling', 'Regulation of signaling by CBL', 'Interleukin-3, Interleukin-5 and GM-CSF signaling', 'Interleukin receptor SHC signaling', 'CLEC7A/inflammasome pathway', 'CLEC7A (Dectin-1) induces NFAT activation', 'CLEC7A (Dectin-1) signaling', 'Dectin-1 mediated noncanonical NF-kB signaling', 'Dectin-2 family', 'CD209 (DC-SIGN) signaling', 'C-type lectin receptors (CLRs)', 'NOD1/2 Signaling Pathway', 'The NLRP3 inflammasome', 'Inflammasomes', 'The IPAF inflammasome', 'The NLRP1 inflammasome', 'The AIM2 inflammasome', 'Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways', 'Neutrophil degranulation', 'Toll Like Receptor 3 (TLR3) Cascade', 'TICAM1-dependent activation of IRF3/IRF7', 'TLR3-mediated TICAM1-dependent programmed cell death', 'TICAM1,TRAF6-dependent induction of TAK1 complex', 'TICAM1, RIP1-mediated IKK complex recruitment', 'Regulation of TP53 Activity', 'Regulation of TP53 Activity through Association with Co-factors', 'Metal sequestration by antimicrobial proteins', 'Beta defensins', 'Alpha-defensins', 'Defensins', 'Ion influx/efflux at host-pathogen interface', 'Antimicrobial peptides', 'Cross-presentation of particulate exogenous antigens (phagosomes)', 'ER-Phagosome pathway', 'Endosomal/Vacuolar pathway', 'Cross-presentation of soluble exogenous antigens (endosomes)', 'Antigen processing-Cross presentation', 'Antigen Presentation: Folding, assembly and peptide loading of class I MHC', 'Antigen processing: Ubiquitination & Proteasome degradation', 'Class I MHC mediated antigen processing & presentation', 'Advanced glycosylation endproduct receptor signaling', 'DAP12 interactions', 'Alternative complement activation', 'Ficolins bind to repetitive carbohydrate structures on the target cell surface', 'Lectin pathway of complement activation', 'Classical antibody-mediated complement activation', 'Creation of C4 and C2 activators', 'Initial triggering of complement', 'Terminal pathway of complement', 'Activation of C3 and C5', 'Regulation of Complement cascade', 'Complement cascade', 'Alpha-protein kinase 1 signaling pathway', 'IRAK1 recruits IKK complex', 'IRAK2 mediated activation of TAK1 complex', 'MyD88:MAL(TIRAP) cascade initiated on plasma membrane', 'Toll Like Receptor TLR6:TLR2 Cascade', 'Toll Like Receptor TLR1:TLR2 Cascade', 'Toll Like Receptor 2 (TLR2) Cascade', 'Transfer of LPS from LBP carrier to CD14', 'Toll Like Receptor 4 (TLR4) Cascade', 'Signaling by the B Cell Receptor (BCR)', 'CD22 mediated BCR regulation', 'Neurotransmitter receptors and postsynaptic signal transmission', 'Acetylcholine binding and downstream events', 'Presynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable nicotinic acetylcholine receptors', 'Highly sodium permeable acetylcholine nicotinic receptors', 'Postsynaptic nicotinic acetylcholine receptors', 'Highly calcium permeable postsynaptic nicotinic acetylcholine receptors', 'Activation of kainate receptors upon glutamate binding', 'Presynaptic function of Kainate receptors', 'Ionotropic activity of kainate receptors', 'Activation of Ca-permeable Kainate Receptor', 'Activation of Na-permeable kainate receptors', 'GABA receptor activation', 'GABA B receptor activation', 'Activation of GABAB receptors', 'Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits', 'Adenylate cyclase inhibitory pathway', 'Norepinephrine Neurotransmitter Release Cycle', 'Dopamine Neurotransmitter Release Cycle', 'Serotonin Neurotransmitter Release Cycle', 'Glutamate Neurotransmitter Release Cycle', 'Astrocytic Glutamate-Glutamine Uptake And Metabolism', 'Acetylcholine Neurotransmitter Release Cycle', 'Degradation of GABA', 'Reuptake of GABA', 'GABA synthesis', 'GABA synthesis, release, reuptake and degradation', 'Neurotransmitter release cycle', 'Presynaptic depolarization and calcium channel opening', 'Neurotransmitter uptake and metabolism In glial cells', 'Enzymatic degradation of dopamine by COMT', 'Enzymatic degradation of Dopamine by monoamine oxidase', 'Dopamine clearance from the synaptic cleft', 'Metabolism of serotonin', 'Serotonin clearance from the synaptic cleft', 'Neurotransmitter clearance', 'Transmission across Chemical Synapses', 'PDE3B signalling', 'PKB-mediated events', 'Activation of AKT2', 'Other interleukin signaling', 'PI3K Cascade', 'IRS-mediated signalling', 'SOS-mediated signalling', 'IRS-related events triggered by IGF1R', 'IGF1R signaling cascade', 'SHC-related events triggered by IGF1R', 'Inhibition of TSC complex formation by PKB', 'mTORC1-mediated signalling', 'mTOR signalling', 'Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)', 'Signaling by NTRKs', 'Signaling by NTRK3 (TRKC)', 'Activated NTRK3 signals through PLCG1', 'NTRK3 as a dependence receptor', 'NTF3 activates NTRK3 signaling', 'Activated NTRK3 signals through PI3K', 'Activated NTRK3 signals through RAS', 'Protein-protein interactions at synapses', 'Receptor-type tyrosine-protein phosphatases', 'Synaptic adhesion-like molecules', 'Neurexins and neuroligins', 'Signaling by NTRK2 (TRKB)', 'Activated NTRK2 signals through FRS2 and FRS3', 'BDNF activates NTRK2 (TRKB) signaling', 'Activated NTRK2 signals through CDK5', 'Activated NTRK2 signals through PLCG1', 'Activated NTRK2 signals through PI3K', 'NTF4 activates NTRK2 (TRKB) signaling', 'Activated NTRK2 signals through FYN', 'NTRK2 activates RAC1', 'Activated NTRK2 signals through RAS', 'NTF3 activates NTRK2 (TRKB) signaling', 'Expression and Processing of Neurotrophins', 'MyD88 cascade initiated on plasma membrane', 'Toll Like Receptor 10 (TLR10) Cascade', 'Toll Like Receptor 5 (TLR5) Cascade', 'Regulation of TLR by endogenous ligand', 'TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation', 'IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation', 'IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation', 'MyD88 dependent cascade initiated on endosome', 'TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling', 'Toll Like Receptor 9 (TLR9) Cascade', 'Toll Like Receptor 7/8 (TLR7/8) Cascade', 'Toll-like Receptor Cascades', 'Trafficking and processing of endosomal TLR', 'Innate Immune System', 'Extra-nuclear estrogen signaling', 'Transcriptional Regulation by VENTX', 'NCAM signaling for neurite out-growth', 'NCAM1 interactions', 'Insulin receptor signalling cascade', 'IRS activation', 'Signal attenuation', 'Insulin receptor recycling', 'Signaling by Insulin receptor', 'Interleukin-2 signaling', 'Interleukin-9 signaling', 'Interleukin-15 signaling', 'Interleukin-2 family signaling', 'Interleukin-21 signaling', 'FGFR2 alternative splicing', 'Signaling by FGFR2', 'Negative regulation of FGFR2 signaling', 'FGFR2 ligand binding and activation', 'FGFR2c ligand binding and activation', 'FGFR2b ligand binding and activation', 'Downstream signaling of activated FGFR2', 'PI-3K cascade:FGFR2', 'FRS-mediated FGFR2 signaling', 'Phospholipase C-mediated cascade; FGFR2', 'SHC-mediated cascade:FGFR2', 'Signaling by FGFR', 'Signaling by FGFR4', 'FGFR4 ligand binding and activation', 'betaKlotho-mediated ligand binding', 'Signaling by FGFR1', 'FGFR1 ligand binding and activation', 'FGFR1b ligand binding and activation', 'FGFR1c and Klotho ligand binding and activation', 'FGFR1c ligand binding and activation', 'Negative regulation of FGFR1 signaling', 'FGFRL1 modulation of FGFR1 signaling', 'Downstream signaling of activated FGFR1', 'FRS-mediated FGFR1 signaling', 'SHC-mediated cascade:FGFR1', 'PI-3K cascade:FGFR1', 'Phospholipase C-mediated cascade: FGFR1', 'RUNX1 regulates transcription of genes involved in differentiation of HSCs', 'RUNX1 regulates transcription of genes involved in differentiation of myeloid cells', 'RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)', 'Transcriptional regulation by RUNX1', 'RUNX1 regulates transcription of genes involved in WNT signaling', 'RUNX1 regulates transcription of genes involved in differentiation of keratinocytes', 'RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function', 'Regulation of RUNX1 Expression and Activity', 'RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known', 'RUNX1 regulates estrogen receptor mediated transcription', 'RUNX1 regulates transcription of genes involved in interleukin signaling', 'RUNX1 regulates transcription of genes involved in BCR signaling', 'Noncanonical activation of NOTCH3', 'NOTCH3 Activation and Transmission of Signal to the Nucleus', 'Signaling by NOTCH3', 'NOTCH3 Intracellular Domain Regulates Transcription', 'NOTCH4 Activation and Transmission of Signal to the Nucleus', 'Negative regulation of NOTCH4 signaling', 'Signaling by NOTCH4', 'NOTCH4 Intracellular Domain Regulates Transcription', 'Pre-NOTCH Expression and Processing', 'Pre-NOTCH Processing in the Endoplasmic Reticulum', 'Signaling by BMP', 'Degradation of GLI1 by the proteasome', 'GLI3 is processed to GLI3R by the proteasome', "Hedgehog 'off' state", 'Degradation of GLI2 by the proteasome', 'Activation of SMO', 'Ligand-receptor interactions', "Hedgehog 'on' state", 'GLI proteins bind promoters of Hh responsive genes to promote transcription', 'Transcriptional regulation by RUNX2', 'RUNX2 regulates genes involved in cell migration', 'RUNX2 regulates genes involved in differentiation of myeloid cells', 'RUNX1 regulates expression of components of tight junctions', 'Signaling by Hippo', 'YAP1- and WWTR1 (TAZ)-stimulated gene expression', 'Signaling by ERBB4', 'Prolactin receptor signaling', 'Signaling by PDGF', 'Signaling by SCF-KIT', 'Meiosis', 'Meiotic synapsis', 'Meiotic recombination', 'Cell Cycle, Mitotic', 'M Phase', 'Regulation of mitotic cell cycle', 'APC/C-mediated degradation of cell cycle proteins', 'APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1', 'Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase', 'Autodegradation of Cdh1 by Cdh1:APC/C', 'Regulation of APC/C activators between G1/S and early anaphase', 'Phosphorylation of Emi1', 'SCF-beta-TrCP mediated degradation of Emi1', 'Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins', 'APC/C:Cdc20 mediated degradation of mitotic proteins', 'APC/C:Cdc20 mediated degradation of Cyclin B', 'Cdc20:Phospho-APC/C mediated degradation of Cyclin A', 'APC/C:Cdc20 mediated degradation of Securin', 'APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint', 'APC-Cdc20 mediated degradation of Nek2A', 'Phosphorylation of the APC/C', 'Chromosome Maintenance', 'Nucleosome assembly', 'Deposition of new CENPA-containing nucleosomes at the centromere', 'Telomere Maintenance', 'Extension of Telomeres', 'Telomere C-strand (Lagging Strand) Synthesis', 'Polymerase switching on the C-strand of the telomere', 'Telomere C-strand synthesis initiation', 'Processive synthesis on the C-strand of the telomere', 'Telomere Extension By Telomerase', 'Packaging Of Telomere Ends', 'Cell-Cell communication', 'Nephrin family interactions', 'Signal regulatory protein family interactions', 'Cellular responses to external stimuli', 'Cellular responses to stress', 'Response of EIF2AK4 (GCN2) to amino acid deficiency', 'Cellular response to heat stress', 'HSF1-dependent transactivation', 'Attenuation phase', 'HSF1 activation', 'Regulation of HSF1-mediated heat shock response', 'Cellular Senescence', 'HSP90 chaperone cycle for steroid hormone receptors (SHR)', 'Amino acids regulate mTORC1', 'Response of EIF2AK1 (HRI) to heme deficiency', 'Response to metal ions', 'Metallothioneins bind metals', 'MTF1 activates gene expression', 'Chromatin organization', 'Chromatin modifying enzymes', 'PKMTs methylate histone lysines', 'HDMs demethylate histones', 'RMTs methylate histone arginines', 'HATs acetylate histones', 'HDACs deacetylate histones', 'Circadian Clock', 'RORA activates gene expression', 'NR1D1 (REV-ERBA) represses gene expression', 'BMAL1:CLOCK,NPAS2 activates circadian gene expression', 'Developmental Biology', 'Transcriptional regulation of pluripotent stem cells', 'POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation', 'POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation', 'Activation of HOX genes during differentiation', 'Activation of anterior HOX genes in hindbrain development during early embryogenesis', 'LGI-ADAM interactions', 'Keratinization', 'Formation of the cornified envelope', 'Myogenesis', 'Transcriptional regulation of white adipocyte differentiation', 'Regulation of beta-cell development', 'Regulation of gene expression in early pancreatic precursor cells', 'Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells', 'Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells', 'Regulation of gene expression in beta cells', 'AKT-mediated inactivation of FOXO1A', 'Signaling by NODAL', 'Regulation of signaling by NODAL', 'Transcriptional regulation of granulopoiesis', 'Axon guidance', 'Signaling by ROBO receptors', 'Regulation of cortical dendrite branching', 'Regulation of expression of SLITs and ROBOs', 'Regulation of commissural axon pathfinding by SLIT and ROBO', 'Inactivation of CDC42 and RAC1', 'Activation of RAC1', 'SLIT2:ROBO1 increases RHOA activity', 'ROBO receptors bind AKAP5', 'Role of ABL in ROBO-SLIT signaling', 'Nonsense-Mediated Decay (NMD)', 'Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)', 'Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)', 'L1CAM interactions', 'Interaction between L1 and Ankyrins', 'Neurofascin interactions', 'CHL1 interactions', 'Recycling pathway of L1', 'NrCAM interactions', 'Signal transduction by L1', 'EPH-Ephrin signaling', 'EPH-ephrin mediated repulsion of cells', 'Ephrin signaling', 'EPHA-mediated growth cone collapse', 'EPHB-mediated forward signaling', 'RET signaling', 'Netrin-1 signaling', 'Netrin mediated repulsion signals', 'DCC mediated attractive signaling', 'DSCAM interactions', 'Role of second messengers in netrin-1 signaling', 'Reelin signalling pathway', 'Digestion and absorption', 'Digestion', 'Digestion of dietary lipid', 'Digestion of dietary carbohydrate', 'Intestinal absorption', 'Intestinal hexose absorption', 'Intestinal lipid absorption', 'Disease', 'Diseases of glycosylation', 'Diseases associated with glycosylation precursor biosynthesis', 'Defective GFPT1 causes CMSTA1', 'Defective PGM1 causes PGM1-CDG (CDG1t)', 'Defective NEU1 causes sialidosis', 'Defective DPM3 causes DPM3-CDG (CDG-1o)', 'Defective GALE can cause Epimerase-deficiency galactosemia (EDG)', 'Defective GALK1 can cause Galactosemia II (GALCT2)', 'Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2', 'Defective GALT can cause Galactosemia', 'Defective DHDDS causes retinitis pigmentosa 59', 'Defective MPI causes MPI-CDG (CDG-1b)', 'Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ', 'Defective DOLK causes DOLK-CDG (CDG-1m)', 'Defective DPM1 causes DPM1-CDG (CDG-1e)', 'Defective DPM2 causes DPM2-CDG (CDG-1u)', 'Defective PMM2 causes PMM2-CDG (CDG-1a)', 'Diseases associated with glycosaminoglycan metabolism', 'Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)', 'Defective ST3GAL3 causes MCT12 and EIEE15', 'Defective PAPSS2 causes SEMD-PA', 'Defective EXT1 causes exostoses 1, TRPS2 and CHDS', 'Defective SLC26A2 causes chondrodysplasias', 'Defective HEXB causes GM2G2', 'Defective B3GALT6 causes EDSP2 and SEMDJL1', 'Defective CHST14 causes EDS, musculocontractural type', 'Defective CHST3 causes SEDCJD', 'Defective CHST6 causes MCDC1', 'Defective B3GAT3 causes JDSSDHD', 'Defective B4GALT7 causes EDS, progeroid type', 'Defective EXT2 causes exostoses 2', 'Defective HEXA causes GM2G1', 'Defective CHSY1 causes TPBS', 'Diseases associated with O-glycosylation of proteins', 'Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2', 'O-linked glycosylation', 'O-glycosylation of TSR domain-containing proteins', 'O-linked glycosylation of mucins', 'Termination of O-glycan biosynthesis', 'Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3', 'Defective LFNG causes SCDO3', 'Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)', 'Defective LARGE causes MDDGA6 and MDDGB6', 'Defective GALNT12 causes colorectal cancer 1 (CRCS1)', 'Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1', 'Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)', 'Defective B3GALTL causes Peters-plus syndrome (PpS)', 'Diseases associated with N-glycosylation of proteins', 'Defective ALG2 causes ALG2-CDG (CDG-1i)', 'Defective ALG12 causes ALG12-CDG (CDG-1g)', 'Defective ALG1 causes ALG1-CDG (CDG-1k)', 'Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)', 'Defective ALG6 causes ALG6-CDG (CDG-1c)', 'Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2', 'Defective MGAT2 causes MGAT2-CDG (CDG-2a)', 'Defective MOGS causes MOGS-CDG (CDG-2b)', 'Defective ALG8 causes ALG8-CDG (CDG-1h)', 'Defective ALG9 causes ALG9-CDG (CDG-1l)', 'Defective RFT1 causes RFT1-CDG (CDG-1n)', 'Defective ALG3 causes ALG3-CDG (CDG-1d)', 'Defective MAN1B1 causes MRT15', 'Defective ALG11 causes ALG11-CDG (CDG-1p)', 'Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)', 'Defective MPDU1 causes MPDU1-CDG (CDG-1f)', 'Infectious disease', 'Listeria monocytogenes entry into host cells', 'InlB-mediated entry of Listeria monocytogenes into host cell', 'InlA-mediated entry of Listeria monocytogenes into host cells', 'HIV Infection', 'HIV Life Cycle', 'Early Phase of HIV Life Cycle', 'Binding and entry of HIV virion', 'Integration of provirus', 'Autointegration results in viral DNA circles', '2-LTR circle formation', 'Integration of viral DNA into host genomic DNA', 'Reverse Transcription of HIV RNA', 'Minus-strand DNA synthesis', 'Plus-strand DNA synthesis', 'Uncoating of the HIV Virion', 'Late Phase of HIV Life Cycle', 'Assembly Of The HIV Virion', 'Synthesis and processing of ENV and VPU', 'Synthesis And Processing Of GAG, GAGPOL Polyproteins', 'Membrane binding and targetting of GAG proteins', 'Transcription of the HIV genome', 'Formation of HIV elongation complex in the absence of HIV Tat', 'RNA Polymerase II Transcription Pre-Initiation And Promoter Opening', 'Formation of RNA Pol II elongation complex ', 'HIV Transcription Elongation', 'Formation of the HIV-1 Early Elongation Complex', 'Formation of the Early Elongation Complex', 'Abortive elongation of HIV-1 transcript in the absence of Tat', 'Tat-mediated elongation of the HIV-1 transcript', 'Formation of HIV-1 elongation complex containing HIV-1 Tat', 'RNA Polymerase II Transcription Elongation', 'Pausing and recovery of Tat-mediated HIV elongation', 'HIV elongation arrest and recovery', 'RNA Polymerase II HIV Promoter Escape', 'RNA Polymerase II Promoter Escape', 'HIV Transcription Initiation', 'RNA Polymerase II Transcription Initiation', 'Pausing and recovery of HIV elongation', 'Tat-mediated HIV elongation arrest and recovery', 'RNA Pol II CTD phosphorylation and interaction with CE during HIV infection', 'RNA Pol II CTD phosphorylation and interaction with CE', 'RNA Polymerase II Transcription', 'RNA Polymerase II Transcription Termination', 'RNA polymerase II transcribes snRNA genes', 'Generic Transcription Pathway', 'Notch-HLH transcription pathway', 'Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors', 'TFAP2 (AP-2) family regulates transcription of cell cycle factors', 'TFAP2 (AP-2) family regulates transcription of growth factors and their receptors', 'Activation of the TFAP2 (AP-2) family of transcription factors', 'TFAP2 (AP-2) family regulates transcription of other transcription factors', 'TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation', 'Negative regulation of activity of TFAP2 (AP-2) family transcription factors', 'Transcriptional regulation by RUNX3', 'RUNX3 Regulates Immune Response and Cell Migration', 'RUNX3 regulates BCL2L11 (BIM) transcription', 'RUNX3 regulates CDKN1A transcription', 'RUNX3 regulates NOTCH signaling', 'RUNX3 regulates p14-ARF', 'Regulation of RUNX3 expression and activity', 'RUNX3 regulates WNT signaling', 'RUNX3 regulates YAP1-mediated transcription', 'RUNX3 regulates RUNX1-mediated transcription', 'Transcriptional Regulation by MECP2', 'MECP2 regulates neuronal receptors and channels', 'MECP2 regulates transcription of genes involved in GABA signaling', 'MECP2 regulates transcription of neuronal ligands', 'Regulation of MECP2 expression and activity', 'MECP2 regulates transcription factors', 'Signaling by NOTCH', 'Nuclear Receptor transcription pathway', 'FOXO-mediated transcription', 'FOXO-mediated transcription of cell death genes', 'FOXO-mediated transcription of cell cycle genes', 'FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes', 'Regulation of localization of FOXO transcription factors', 'Regulation of FOXO transcriptional activity by acetylation', 'Transcriptional Regulation by E2F6', 'RNA Polymerase II Transcription Initiation And Promoter Clearance', 'RNA Polymerase II Pre-transcription Events', 'Rev-mediated nuclear export of HIV RNA', 'Budding and maturation of HIV virion', 'Host Interactions of HIV factors', 'Interactions of Tat with host cellular proteins', 'Interactions of Vpr with host cellular proteins', 'Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization', 'Vpr-mediated nuclear import of PICs', 'APOBEC3G mediated resistance to HIV-1 infection', 'Vpu mediated degradation of CD4', 'Interactions of Rev with host cellular proteins', 'Nuclear import of Rev protein', 'The role of Nef in HIV-1 replication and disease pathogenesis', 'Nef and signal transduction', 'Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters', 'Nef Mediated CD4 Down-regulation', 'Nef Mediated CD8 Down-regulation', 'Nef mediated downregulation of CD28 cell surface expression', 'Nef mediated downregulation of MHC class I complex cell surface expression', 'Vif-mediated degradation of APOBEC3G', 'Uptake and actions of bacterial toxins', 'Intestinal infectious diseases', 'Uptake and function of anthrax toxins', 'Neurotoxicity of clostridium toxins', 'Toxicity of botulinum toxin type E (BoNT/E)', 'Toxicity of botulinum toxin type F (BoNT/F)', 'Toxicity of tetanus toxin (TeNT)', 'Toxicity of botulinum toxin type A (BoNT/A)', 'Toxicity of botulinum toxin type C (BoNT/C)', 'Toxicity of botulinum toxin type D (BoNT/D)', 'Toxicity of botulinum toxin type G (BoNT/G)', 'Toxicity of botulinum toxin type B (BoNT/B)', 'Uptake and function of diphtheria toxin', 'Influenza Infection', 'Influenza Life Cycle', 'Export of Viral Ribonucleoproteins from Nucleus', 'Viral RNP Complexes in the Host Cell Nucleus', 'NEP/NS2 Interacts with the Cellular Export Machinery', 'Influenza Viral RNA Transcription and Replication', 'Viral mRNA Translation', 'Viral Messenger RNA Synthesis', 'vRNP Assembly', 'cRNA Synthesis', 'vRNA Synthesis', 'Entry of Influenza Virion into Host Cell via Endocytosis', 'Fusion and Uncoating of the Influenza Virion', 'Fusion of the Influenza Virion to the Host Cell Endosome', 'Uncoating of the Influenza Virion', 'Transport of Ribonucleoproteins into the Host Nucleus', 'Virus Assembly and Release', 'Release', 'Budding', 'Packaging of Eight RNA Segments', 'Assembly of Viral Components at the Budding Site', 'Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus', 'Host Interactions with Influenza Factors', 'NS1 Mediated Effects on Host Pathways', 'Inhibition of Interferon Synthesis', 'Inhibition of IFN-beta', 'Inhibition of Host mRNA Processing and RNA Silencing', 'Inhibition of PKR', 'Influenza Virus Induced Apoptosis', 'HCMV Infection', 'HCMV Early Events', 'HCMV Late Events', 'Infection with Mycobacterium tuberculosis', 'Response of Mtb to phagocytosis', 'Suppression of phagosomal maturation', 'Blockage of phagosome acidification', 'Inhibition of nitric oxide production', 'Prevention of phagosomal-lysosomal fusion', 'Manipulation of host energy metabolism', 'Suppression of apoptosis', 'Suppression of autophagy', 'Inhibition of membrane repair', 'Escape of Mtb from the phagocyte', 'Phagocyte cell death caused by cytosolic Mtb', 'Antimicrobial action and antimicrobial resistance in Mtb', 'Modulation by Mtb of host immune system', 'Diseases of signal transduction', 'Signaling by FGFR in disease', 'Signaling by FGFR1 in disease', 'FGFR1 mutant receptor activation', 'Signaling by cytosolic FGFR1 fusion mutants', 'Signaling by FGFR1 amplification mutants', 'Signaling by activated point mutants of FGFR1', 'Signaling by plasma membrane FGFR1 fusions', 'Signaling by FGFR3 in disease', 'Signaling by FGFR3 fusions in cancer', 'Signaling by FGFR3 point mutants in cancer', 'FGFR3 mutant receptor activation', 't(4;14) translocations of FGFR3', 'Signaling by activated point mutants of FGFR3', 'Signaling by FGFR2 in disease', 'FGFR2 mutant receptor activation', 'Activated point mutants of FGFR2', 'Signaling by FGFR2 fusions', 'Signaling by FGFR2 amplification mutants', 'Signaling by FGFR2 IIIa TM', 'Signaling by FGFR4 in disease', 'FGFR4 mutant receptor activation', 'Signaling by WNT in cancer', 'Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling', 'Misspliced GSK3beta mutants stabilize beta-catenin', "TCF7L2 mutants don't bind CTBP", 'phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex', "T41 mutants of beta-catenin aren't phosphorylated", "S33 mutants of beta-catenin aren't phosphorylated", "S37 mutants of beta-catenin aren't phosphorylated", "S45 mutants of beta-catenin aren't phosphorylated", 'XAV939 inhibits tankyrase, stabilizing AXIN', 'truncated APC mutants destabilize the destruction complex', 'APC truncation mutants are not K63 polyubiquitinated', 'APC truncation mutants have impaired AXIN binding', 'WNT ligand secretion is abrogated by the PORCN inhibitor LGK974', 'AMER1 mutants destabilize the destruction complex', 'Truncations of AMER1 destabilize the destruction complex', 'Deletions in the AMER1 gene destabilize the destruction complex', 'RNF mutants show enhanced WNT signaling and proliferation', 'AXIN mutants destabilize the destruction complex, activating WNT signaling', 'Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling', 'AXIN missense mutants destabilize the destruction complex', 'Signaling by NOTCH1 in Cancer', 'Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant', 'Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant', 'Signaling by NOTCH1 PEST Domain Mutants in Cancer', 'Constitutive Signaling by NOTCH1 PEST Domain Mutants', 'FBXW7 Mutants and NOTCH1 in Cancer', 'Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling', 'Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer', 'Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants', 'Signaling by NOTCH1 HD Domain Mutants in Cancer', 'Constitutive Signaling by NOTCH1 HD Domain Mutants', 'Signaling by ERBB2 in Cancer', 'Signaling by ERBB2 KD Mutants', 'Drug resistance in ERBB2 KD mutants', 'Resistance of ERBB2 KD mutants to lapatinib', 'Resistance of ERBB2 KD mutants to AEE788', 'Resistance of ERBB2 KD mutants to trastuzumab', 'Resistance of ERBB2 KD mutants to afatinib', 'Resistance of ERBB2 KD mutants to osimertinib', 'Resistance of ERBB2 KD mutants to neratinib', 'Resistance of ERBB2 KD mutants to tesevatinib', 'Resistance of ERBB2 KD mutants to sapitinib', 'Constitutive Signaling by Overexpressed ERBB2', 'Signaling by EGFR in Cancer', 'Signaling by Ligand-Responsive EGFR Variants in Cancer', 'Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants', 'Signaling by EGFRvIII in Cancer', 'Constitutive Signaling by EGFRvIII', 'Signaling by Overexpressed Wild-Type EGFR in Cancer', 'Inhibition of Signaling by Overexpressed EGFR', 'PI3K/AKT Signaling in Cancer', 'PTEN Loss of Function in Cancer', 'Constitutive Signaling by AKT1 E17K in Cancer', 'Constitutive Signaling by Aberrant PI3K in Cancer', 'Hh mutants abrogate ligand secretion', "Hh mutants that don't undergo autocatalytic processing are degraded by ERAD", 'Hedgehog ligand biogenesis', 'Release of Hh-Np from the secreting cell', 'HHAT G278V abrogates palmitoylation of Hh-Np', 'Signaling by TGF-beta Receptor Complex in Cancer', 'Loss of Function of TGFBR2 in Cancer', 'TGFBR2 MSI Frameshift Mutants in Cancer', 'TGFBR2 Kinase Domain Mutants in Cancer', 'Loss of Function of TGFBR1 in Cancer', 'TGFBR1 LBD Mutants in Cancer', 'TGFBR1 KD Mutants in Cancer', 'Loss of Function of SMAD4 in Cancer', 'SMAD4 MH2 Domain Mutants in Cancer', 'Loss of Function of SMAD2/3 in Cancer', 'SMAD2/3 Phosphorylation Motif Mutants in Cancer', 'SMAD2/3 MH2 Domain Mutants in Cancer', 'Diseases associated with visual transduction', 'Retinoid metabolism disease events', 'Retinoid metabolism and transport', 'Visual phototransduction', 'The retinoid cycle in cones (daylight vision)', 'The canonical retinoid cycle in rods (twilight vision)', 'Biosynthesis of A2E, implicated in retinal degradation', 'Inactivation, recovery and regulation of the phototransduction cascade', 'Activation of the phototransduction cascade', 'The phototransduction cascade', 'Retinoid cycle disease events', 'Diseases of metabolism', 'Defects in vitamin and cofactor metabolism', 'Defects in biotin (Btn) metabolism', 'Defective HLCS causes multiple carboxylase deficiency', 'Metabolism of water-soluble vitamins and cofactors', 'Vitamin B1 (thiamin) metabolism', 'Vitamins B6 activation to pyridoxal phosphate', 'Molybdenum cofactor biosynthesis', 'Cobalamin (Cbl, vitamin B12) transport and metabolism', 'Metabolism of folate and pterines', 'Vitamin C (ascorbate) metabolism', 'Vitamin B5 (pantothenate) metabolism', 'Coenzyme A biosynthesis', 'Vitamin B2 (riboflavin) metabolism', 'Biotin transport and metabolism', 'Defective BTD causes biotidinase deficiency', 'Defects in cobalamin (B12) metabolism', 'Defective MMAA causes methylmalonic aciduria type cblA', 'Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC', 'Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD', 'Defective MUT causes methylmalonic aciduria mut type', 'Defective TCN2 causes hereditary megaloblastic anemia', 'Defective CD320 causes methylmalonic aciduria', 'Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF', 'Defective GIF causes intrinsic factor deficiency', 'Defective CUBN causes hereditary megaloblastic anemia 1', 'Defective AMN causes hereditary megaloblastic anemia 1', 'Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)', 'Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE', 'Defective MMAB causes methylmalonic aciduria type cblB', 'Defective MTR causes methylmalonic aciduria and homocystinuria type cblG', 'Metabolic disorders of biological oxidation enzymes', 'Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)', 'Metabolism of steroid hormones', 'Glucocorticoid biosynthesis', 'Androgen biosynthesis', 'Estrogen biosynthesis', 'Mineralocorticoid biosynthesis', 'Pregnenolone biosynthesis', 'Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)', 'Class A/1 (Rhodopsin-like receptors)', 'Peptide ligand-binding receptors', 'Chemokine receptors bind chemokines', 'Orexin and neuropeptides FF and QRFP bind to their respective receptors', 'Relaxin receptors', 'Tachykinin receptors bind tachykinins', 'Vasopressin-like receptors', 'Formyl peptide receptors bind formyl peptides and many other ligands', 'Nucleotide-like (purinergic) receptors', 'P2Y receptors', 'Adenosine P1 receptors', 'Hormone ligand-binding receptors', 'Amine ligand-binding receptors', 'Muscarinic acetylcholine receptors', 'Adrenoceptors', 'Dopamine receptors', 'Histamine receptors', 'Serotonin receptors', 'Lysosphingolipid and LPA receptors', 'Hydroxycarboxylic acid-binding receptors', 'Free fatty acid receptors', 'Eicosanoid ligand-binding receptors', 'Prostanoid ligand receptors', 'Leukotriene receptors', 'Opsins', 'G alpha (z) signalling events', 'G-protein beta:gamma signalling', 'G beta:gamma signalling through CDC42', 'G beta:gamma signalling through BTK', 'G beta:gamma signalling through PI3Kgamma', 'G beta:gamma signalling through PLC beta', 'G alpha (i) signalling events', 'Opioid Signalling', 'G-protein mediated events', 'Adenylate cyclase activating pathway', 'PLC beta mediated events', 'Ca-dependent events', 'phospho-PLA2 pathway', 'DARPP-32 events', 'G-protein activation', 'G alpha (12/13) signalling events', 'G alpha (q) signalling events', 'Effects of PIP2 hydrolysis', 'Arachidonate production from DAG', 'Gastrin-CREB signalling pathway via PKC and MAPK', 'EGFR Transactivation by Gastrin', 'G alpha (s) signalling events', 'Olfactory Signaling Pathway', 'Defective CYP19A1 causes Aromatase excess syndrome (AEXS)', 'Phase I - Functionalization of compounds', 'Aryl hydrocarbon receptor signalling', 'Amine Oxidase reactions', 'PAOs oxidise polyamines to amines', 'Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB', 'FMO oxidises nucleophiles', 'COX reactions', 'Ethanol oxidation', 'Cytochrome P450 - arranged by substrate type', 'Miscellaneous substrates', 'Eicosanoids', 'Endogenous sterols', 'Sterols are 12-hydroxylated by CYP8B1', 'Fatty acids', 'Xenobiotics', 'Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2', 'CYP2E1 reactions', 'Vitamins', 'Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)', 'Phase II - Conjugation of compounds', 'Acetylation', 'Methylation', 'Amino Acid conjugation', 'Conjugation of carboxylic acids', 'Conjugation of phenylacetate with glutamine', 'Conjugation of salicylate with glycine', 'Conjugation of benzoate with glycine', 'Cytosolic sulfonation of small molecules', 'Glutathione conjugation', 'Glutathione synthesis and recycling', 'Glucuronidation', 'Formation of the active cofactor, UDP-glucuronate', 'Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)', 'Vitamin D (calciferol) metabolism', 'Cholesterol biosynthesis', 'Cholesterol biosynthesis via desmosterol', 'Cholesterol biosynthesis via lathosterol', 'Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)', 'Defective GGT1 causes Glutathionuria (GLUTH)', 'Aflatoxin activation and detoxification', 'Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)', 'Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)', 'Defective MAOA causes Brunner syndrome (BRUNS)', 'Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)', 'Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)', 'Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)', 'Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)', 'Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)', 'Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)', 'Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)', 'Defective GGT1 causes Glutathionuria (GLUTH)', 'Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)', 'Defective UGT1A4 causes hyperbilirubinemia', 'Defective FMO3 causes Trimethylaminuria (TMAU)', 'Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)', 'Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)', 'Bile acid and bile salt metabolism', 'Recycling of bile acids and salts', 'Synthesis of bile acids and bile salts', 'Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 24-hydroxycholesterol', 'Synthesis of bile acids and bile salts via 27-hydroxycholesterol', 'Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)', 'Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)', 'Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)', 'Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)', 'Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)', 'Defective ACY1 causes encephalopathy', 'Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)', 'Defective CYP1B1 causes Glaucoma', 'Defective UGT1A1 causes hyperbilirubinemia', 'Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate', 'Phenylketonuria', 'Diseases of carbohydrate metabolism', 'Glycogen storage diseases', 'Glycogen storage disease type Ia (G6PC)', 'Glycogen storage disease type 0 (muscle GYS1)', 'Glycogen storage disease type IV (GBE1)', 'Glycogen storage disease type II (GAA)', 'Severe congenital neutropenia type 4 (G6PC3)', 'Glycogen storage disease type Ib (SLC37A4)', 'Myoclonic epilepsy of Lafora', 'Glycogen storage disease type 0 (liver GYS2)', 'Glycogen storage disease type XV (GYG1)', 'Essential pentosuria', 'Mucopolysaccharidoses', 'MPS IIID - Sanfilippo syndrome D', 'MPS IIIA - Sanfilippo syndrome A', 'MPS IIIC - Sanfilippo syndrome C', 'MPS IV - Morquio syndrome A', 'MPS IV - Morquio syndrome B', 'MPS VII - Sly syndrome', 'MPS II - Hunter syndrome', 'MPS IX - Natowicz syndrome', 'MPS IIIB - Sanfilippo syndrome B', 'MPS VI - Maroteaux-Lamy syndrome', 'MPS I - Hurler syndrome', 'Essential fructosuria', 'Intestinal saccharidase deficiencies', 'Hereditary fructose intolerance', 'Pentose phosphate pathway disease', 'TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P', 'RPIA deficiency: failed conversion of RU5P to R5P', 'TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P', 'RPIA deficiency: failed conversion of R5P to RU5P', 'Diseases associated with surfactant metabolism', 'Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)', 'Surfactant metabolism', 'Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)', 'Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)', 'Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)', 'Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)', 'Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)', 'Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)', 'Diseases of Programmed Cell Death', 'Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function', 'Neurodegenerative Diseases', "Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models", 'Diseases of Cellular Senescence', 'Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects', 'Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects', 'Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4', 'Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6', 'Evasion of Oncogene Induced Senescence Due to p16INK4A Defects', 'Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4', 'Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6', 'Evasion of Oncogene Induced Senescence Due to p14ARF Defects', 'Diseases of Mismatch Repair (MMR)', 'Defective Mismatch Repair Associated With MSH2', 'Defective Mismatch Repair Associated With MSH3', 'Defective Mismatch Repair Associated With MSH6', 'Defective Mismatch Repair Associated With PMS2', 'Defective Mismatch Repair Associated With MLH1', 'Disorders of transmembrane transporters', 'ABC transporter disorders', 'Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B', 'ABC-family proteins mediated transport', 'ABC transporters in lipid homeostasis', 'Mitochondrial ABC transporters', 'Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia', 'Defective ABCG8 causes gallbladder disease 4 and sitosterolemia', 'Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1', 'Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)', 'Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2', 'Defective ABCG5 causes sitosterolemia', 'Defective ABCC2 causes Dubin-Johnson syndrome', 'Metabolism of porphyrins', 'Heme biosynthesis', 'Heme degradation', 'Defective ABCC6 causes pseudoxanthoma elasticum (PXE)', 'Defective ABCA1 causes Tangier disease', 'Plasma lipoprotein assembly, remodeling, and clearance', 'Plasma lipoprotein assembly', 'VLDL assembly', 'HDL assembly', 'Chylomicron assembly', 'Plasma lipoprotein remodeling', 'LDL remodeling', 'HDL remodeling', 'Chylomicron remodeling', 'Assembly of active LPL and LIPC lipase complexes', 'Plasma lipoprotein clearance', 'Chylomicron clearance', 'HDL clearance', 'VLDL clearance', 'VLDLR internalisation and degradation', 'LDL clearance', 'Defective CFTR causes cystic fibrosis', 'Defective ABCD1 causes adrenoleukodystrophy (ALD)', 'Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)', 'Defective ABCC8 can cause hypoglycemias and hyperglycemias', 'Integration of energy metabolism', 'Regulation of insulin secretion', 'Free fatty acids regulate insulin secretion', 'Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion', 'Intracellular metabolism of fatty acids regulates insulin secretion', 'Glucagon-like Peptide-1 (GLP1) regulates insulin secretion', 'Acetylcholine regulates insulin secretion', 'Adrenaline,noradrenaline inhibits insulin secretion', 'AMPK inhibits chREBP transcriptional activation activity', 'PP2A-mediated dephosphorylation of key metabolic factors', 'ChREBP activates metabolic gene expression', 'Insulin effects increased synthesis of Xylulose-5-Phosphate', 'PKA-mediated phosphorylation of key metabolic factors', 'Glucagon signaling in metabolic regulation', 'PKA activation in glucagon signalling', 'SLC transporter disorders', 'Defective SLC6A19 causes Hartnup disorder (HND)', 'Transport of inorganic cations/anions and amino acids/oligopeptides', 'Proton/oligopeptide cotransporters', 'Sodium-coupled phosphate cotransporters', 'Type II Na+/Pi cotransporters', 'Bicarbonate transporters', 'Cation-coupled Chloride cotransporters', 'Amino acid transport across the plasma membrane', 'Sodium/Proton exchangers', 'Organic anion transporters', 'Proton-coupled neutral amino acid transporters', 'Multifunctional anion exchangers', 'Sodium/Calcium exchangers', 'Defective SLC7A9 causes cystinuria (CSNU)', 'Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria', 'Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)', 'Transport of vitamins, nucleosides, and related molecules', 'Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane', 'Transport of nucleotide sugars', 'Transport of organic anions', 'Transport of fatty acids', 'Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)', 'Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)', 'Defective SLC17A5 causes Salla disease (SD) and ISSD', 'Defective SLC33A1 causes spastic paraplegia 42 (SPG42)', 'Defective CP causes aceruloplasminemia (ACERULOP)', 'Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)', 'Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)', 'Defective SLC1A3 causes episodic ataxia 6 (EA6)', 'Defective HK1 causes hexokinase deficiency (HK deficiency)', 'Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)', 'Defective SLC2A10 causes arterial tortuosity syndrome (ATS)', 'Cellular hexose transport', 'Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)', 'Transport of bile salts and organic acids, metal ions and amine compounds', 'Na+/Cl- dependent neurotransmitter transporters', 'Metal ion SLC transporters', 'Zinc transporters', 'Zinc influx into cells by the SLC39 gene family', 'Zinc efflux and compartmentalization by the SLC30 family', 'Organic cation/anion/zwitterion transport', 'Organic anion transport', 'Organic cation transport', 'Sodium-coupled sulphate, di- and tri-carboxylate transporters', 'Proton-coupled monocarboxylate transport', 'Rhesus glycoproteins mediate ammonium transport.', 'Inositol transporters', 'Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)', 'Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)', 'Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)', 'Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)', 'Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)', 'Defective SLC6A19 causes Hartnup disorder (HND)', 'Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)', 'Defective SLC26A4 causes Pendred syndrome (PDS)', 'Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)', 'Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)', 'Vasopressin regulates renal water homeostasis via Aquaporins', 'Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)', 'Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)', 'Defective SLC5A2 causes renal glucosuria (GLYS1)', 'Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)', 'Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)', 'Defective SLC9A9 causes autism 16 (AUTS16)', 'Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)', 'Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)', 'Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)', 'Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)', 'Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)', 'Erythrocytes take up carbon dioxide and release oxygen', 'Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)', 'Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)', 'Variant SLC6A14 may confer susceptibility towards obesity', 'Defective SLC6A5 causes hyperekplexia 3 (HKPX3)', 'Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)', 'Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)', 'Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)', 'Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)', 'Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)', 'Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)', 'Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)', 'Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)', 'Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria', 'Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)', 'Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)', 'Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)', 'Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)', 'Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)', 'Defective SLC12A3 causes Gitelman syndrome (GS)', 'Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)', 'Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)', 'Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)', 'Defective SLC7A7 causes lysinuric protein intolerance (LPI)', 'Defective SLC6A2 causes orthostatic intolerance (OI)', 'Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)', 'Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)', 'Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)', 'Defective SLC12A1 causes Bartter syndrome 1 (BS1)', 'Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)', 'Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)', 'Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)', 'Defective SLC3A1 causes cystinuria (CSNU)', 'Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)', 'Pervasive developmental disorders', 'Loss of function of MECP2 in Rett syndrome', 'Loss of MECP2 binding ability to the NCoR/SMRT complex', 'Loss of MECP2 binding ability to 5mC-DNA', 'Loss of phosphorylation of MECP2 at T308', 'Loss of MECP2 binding ability to 5hmC-DNA', 'Diseases of Base Excision Repair', 'Defective Base Excision Repair Associated with NEIL3', 'Base-Excision Repair, AP Site Formation', 'NEIL3-mediated resolution of ICLs', 'Depurination', 'Cleavage of the damaged purine', 'Recognition and association of DNA glycosylase with site containing an affected purine', 'Depyrimidination', 'Cleavage of the damaged pyrimidine ', 'Recognition and association of DNA glycosylase with site containing an affected pyrimidine', 'Resolution of Abasic Sites (AP sites)', 'APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway', 'Displacement of DNA glycosylase by APEX1', 'Resolution of AP sites via the multiple-nucleotide patch replacement pathway', 'POLB-Dependent Long Patch Base Excision Repair', 'PCNA-Dependent Long Patch Base Excision Repair', 'Resolution of AP sites via the single-nucleotide replacement pathway', 'Abasic sugar-phosphate removal via the single-nucleotide replacement pathway', 'Defective Base Excision Repair Associated with OGG1', 'Defective OGG1 Substrate Processing', 'Defective OGG1 Localization', 'Defective OGG1 Substrate Binding', 'Defective Base Excision Repair Associated with MUTYH', 'Defective MUTYH substrate processing', 'Defective MUTYH substrate binding', 'Defective Base Excision Repair Associated with NEIL1', 'Defective Base Excision Repair Associated with NTHL1', 'Defective NTHL1 substrate binding', 'Defective NTHL1 substrate processing', 'Diseases of Immune System', 'Diseases associated with the TLR signaling cascade', 'IkBA variant leads to EDA-ID', 'TICAM1 deficiency - HSE', 'IRAK4 deficiency (TLR2/4)', 'IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)', 'MyD88 deficiency (TLR2/4)', 'IRAK4 deficiency (TLR5)', 'IKBKB deficiency causes SCID', 'UNC93B1 deficiency - HSE', 'MyD88 deficiency (TLR5)', 'TRAF3 deficiency - HSE', 'TLR3 deficiency - HSE', 'DNA Repair', 'DNA Damage Bypass', 'Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template', 'Translesion synthesis by POLK', 'Translesion Synthesis by POLH', 'Translesion synthesis by REV1', 'Translesion synthesis by POLI', 'Termination of translesion DNA synthesis', 'Recognition of DNA damage by PCNA-containing replication complex', 'Base Excision Repair', 'DNA Damage Reversal', 'MGMT-mediated DNA damage reversal', 'Reversal of alkylation damage by DNA dioxygenases', 'ALKBH2 mediated reversal of alkylation damage', 'ALKBH3 mediated reversal of alkylation damage', 'DNA Replication', 'DNA Replication Pre-Initiation', 'Extracellular matrix organization', 'Laminin interactions', 'Degradation of the extracellular matrix', 'Activation of Matrix Metalloproteinases', 'Collagen degradation', 'Elastic fibre formation', 'Molecules associated with elastic fibres', 'Collagen formation', 'Assembly of collagen fibrils and other multimeric structures', 'Anchoring fibril formation', 'Crosslinking of collagen fibrils', 'Collagen biosynthesis and modifying enzymes', 'Collagen chain trimerization', 'Fibronectin matrix formation', 'Non-integrin membrane-ECM interactions', 'Syndecan interactions', 'Invadopodia formation', 'ECM proteoglycans', 'Gene expression (Transcription)', 'Epigenetic regulation of gene expression', 'Positive epigenetic regulation of rRNA expression', 'ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression', 'B-WICH complex positively regulates rRNA expression', 'DNA methylation', 'TET1,2,3 and TDG demethylate DNA', 'Negative epigenetic regulation of rRNA expression', 'NoRC negatively regulates rRNA expression', 'SIRT1 negatively regulates rRNA expression', 'PRC2 methylates histones and DNA', 'RNA Polymerase I Transcription', 'RNA Polymerase I Transcription Termination', 'RNA Polymerase I Promoter Clearance', 'RNA Polymerase I Promoter Opening', 'RNA Polymerase I Transcription Initiation', 'RNA Polymerase I Promoter Escape', 'Transcription from mitochondrial promoters', 'Mitochondrial transcription initiation', 'Mitochondrial transcription termination', 'Gene Silencing by RNA', 'Small interfering RNA (siRNA) biogenesis', 'MicroRNA (miRNA) biogenesis', 'Post-transcriptional silencing by small RNAs', 'Transcriptional regulation by small RNAs', 'PIWI-interacting RNA (piRNA) biogenesis', 'RNA Polymerase III Transcription', 'RNA Polymerase III Chain Elongation', 'RNA Polymerase III Transcription Initiation', 'RNA Polymerase III Transcription Initiation From Type 2 Promoter', 'RNA Polymerase III Transcription Initiation From Type 3 Promoter', 'RNA Polymerase III Transcription Initiation From Type 1 Promoter', 'RNA Polymerase III Transcription Termination', 'RNA Polymerase III Abortive And Retractive Initiation', 'Hemostasis', 'Factors involved in megakaryocyte development and platelet production', 'Kinesins', 'Platelet activation, signaling and aggregation', 'GP1b-IX-V activation signalling', 'Signal amplification', 'Thromboxane signalling through TP receptor', 'ADP signalling through P2Y purinoceptor 1', 'ADP signalling through P2Y purinoceptor 12', 'Response to elevated platelet cytosolic Ca2+', 'Platelet degranulation ', 'Disinhibition of SNARE formation', 'Thrombin signalling through proteinase activated receptors (PARs)', 'Platelet Aggregation (Plug Formation)', 'Adrenaline signalling through Alpha-2 adrenergic receptor', 'Integrin signaling', 'p130Cas linkage to MAPK signaling for integrins', 'GRB2:SOS provides linkage to MAPK signaling for Integrins ', 'GPVI-mediated activation cascade', 'Dissolution of Fibrin Clot', 'Platelet Adhesion to exposed collagen', 'Platelet homeostasis', 'Prostacyclin signalling through prostacyclin receptor', 'Platelet sensitization by LDL', 'Platelet calcium homeostasis', 'Reduction of cytosolic Ca++ levels', 'Elevation of cytosolic Ca2+ levels', 'Nitric oxide stimulates guanylate cyclase', 'cGMP effects', 'Formation of Fibrin Clot (Clotting Cascade)', 'Extrinsic Pathway of Fibrin Clot Formation', 'Intrinsic Pathway of Fibrin Clot Formation', 'Common Pathway of Fibrin Clot Formation', 'Immune System', 'Cytokine Signaling in Immune system', 'Interferon Signaling', 'Antiviral mechanism by IFN-stimulated genes', 'ISG15 antiviral mechanism', 'OAS antiviral response', 'Interferon alpha/beta signaling', 'Regulation of IFNA signaling', 'Interferon gamma signaling', 'Regulation of IFNG signaling', 'Growth hormone receptor signaling', 'FLT3 Signaling', 'STAT5 Activation', 'TNFR2 non-canonical NF-kB pathway', 'TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway', 'NIK-->noncanonical NF-kB signaling', 'TNFs bind their physiological receptors', 'Signaling by Interleukins', 'Interleukin-10 signaling', 'Interleukin-7 signaling', 'Interleukin-20 family signaling', 'Interleukin-4 and Interleukin-13 signaling', 'Interleukin-12 family signaling', 'Interleukin-27 signaling', 'Interleukin-12 signaling', 'Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation', 'Interleukin-35 Signalling', 'Interleukin-23 signaling', 'Interleukin-17 signaling', 'MAPK1/MAPK3 signaling', 'Adaptive Immune System', 'Rap1 signalling', 'Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell', 'MHC class II antigen presentation', 'Butyrophilin (BTN) family interactions', 'Metabolism', 'Reversible hydration of carbon dioxide', 'Inositol phosphate metabolism', 'IP3 and IP4 transport between cytosol and nucleus', 'IP6 and IP7 transport between cytosol and nucleus', 'Synthesis of pyrophosphates in the cytosol', 'Synthesis of IPs in the ER lumen', 'IPs transport between ER lumen and cytosol', 'Synthesis of IP2, IP, and Ins in the cytosol', 'IPs transport between nucleus and ER lumen', 'Synthesis of IP3 and IP4 in the cytosol', 'IPs transport between ER lumen and nucleus', 'Synthesis of IPs in the nucleus', 'IPs transport between cytosol and ER lumen', 'IPs transport between nucleus and cytosol', 'Metabolism of lipids', 'Triglyceride metabolism', 'Triglyceride biosynthesis', 'Triglyceride catabolism', 'Metabolism of steroids', 'Regulation of cholesterol biosynthesis by SREBP (SREBF)', 'Activation of gene expression by SREBF (SREBP)', 'Lipid particle organization', 'Regulation of lipid metabolism by PPARalpha', 'PPARA activates gene expression', 'Sphingolipid metabolism', 'Sphingolipid de novo biosynthesis', 'Glycosphingolipid metabolism', 'Fatty acid metabolism', 'Fatty acyl-CoA biosynthesis', 'Synthesis of very long-chain fatty acyl-CoAs', 'Arachidonic acid metabolism', 'Synthesis of 5-eicosatetraenoic acids', 'Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)', 'Synthesis of Leukotrienes (LT) and Eoxins (EX)', 'Synthesis of Hepoxilins (HX) and Trioxilins (TrX)', 'Synthesis of Prostaglandins (PG) and Thromboxanes (TX)', 'Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)', 'Synthesis of 15-eicosatetraenoic acid derivatives', 'Synthesis of 12-eicosatetraenoic acid derivatives', 'Peroxisomal lipid metabolism', 'Beta-oxidation of very long chain fatty acids', 'Alpha-oxidation of phytanate', 'Beta-oxidation of pristanoyl-CoA', 'alpha-linolenic (omega3) and linoleic (omega6) acid metabolism', 'alpha-linolenic acid (ALA) metabolism', 'Linoleic acid (LA) metabolism', 'Carnitine metabolism', 'Phospholipid metabolism', 'Glycerophospholipid biosynthesis', 'Acyl chain remodelling of PE', 'Synthesis of PC', 'Hydrolysis of LPE', 'Acyl chain remodelling of PS', 'Synthesis of PA', 'PI and PC transport between ER and Golgi membranes', 'Synthesis of PS', 'Synthesis of PI', 'Acyl chain remodelling of PC', 'Synthesis of CL', 'Acyl chain remodeling of DAG and TAG', 'Synthesis of BMP', 'Acyl chain remodeling of CL', 'Synthesis of PG', 'Synthesis of PE', 'Acyl chain remodelling of PG', 'Acyl chain remodelling of PI', 'Hydrolysis of LPC', 'PI Metabolism', 'PIPs transport between early endosome and Golgi membranes', 'PIPs transport between late endosome and Golgi membranes', 'Synthesis of PIPs at the ER membrane', 'PIPs transport between Golgi and plasma membranes', 'Glycerophospholipid catabolism', 'Synthesis of PIPs at the plasma membrane', 'PIPs transport between early and late endosome membranes', 'PIPs transport between plasma and early endosome membranes', 'Synthesis of PIPs in the nucleus', 'Synthesis of PIPs at the Golgi membrane', 'Synthesis of PIPs at the late endosome membrane', 'Synthesis of PIPs at the early endosome membrane', 'Wax and plasmalogen biosynthesis', 'Plasmalogen biosynthesis', 'Wax biosynthesis', 'Biosynthesis of specialized proresolving mediators (SPMs)', 'Biosynthesis of DPA-derived SPMs', 'Biosynthesis of DPAn-6 SPMs', 'Biosynthesis of DPAn-3 SPMs', 'Biosynthesis of DPAn-3-derived protectins and resolvins', 'Biosynthesis of DPAn-3-derived 13-series resolvins', 'Biosynthesis of DPAn-3-derived maresins', 'Synthesis of Lipoxins (LX)', 'Biosynthesis of DHA-derived SPMs', 'Biosynthesis of aspirin-triggered D-series resolvins', 'Biosynthesis of protectins', 'Biosynthesis of DHA-derived sulfido conjugates', 'Biosynthesis of maresin conjugates in tissue regeneration (MCTR)', 'Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)', 'Biosynthesis of maresins', 'Biosynthesis of maresin-like SPMs', 'Biosynthesis of D-series resolvins', 'Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives', 'Biosynthesis of EPA-derived SPMs', 'Biosynthesis of E-series 18(R)-resolvins', 'Biosynthesis of E-series 18(S)-resolvins', 'The citric acid (TCA) cycle and respiratory electron transport', 'Pyruvate metabolism and Citric Acid (TCA) cycle', 'Interconversion of 2-oxoglutarate and 2-hydroxyglutarate', 'Citric acid cycle (TCA cycle)', 'Pyruvate metabolism', 'Regulation of pyruvate dehydrogenase (PDH) complex', 'Biological oxidations', 'Abacavir transport and metabolism', 'Abacavir metabolism', 'Abacavir transmembrane transport', 'Metabolism of vitamins and cofactors', 'Metabolism of fat-soluble vitamins', 'Vitamin E', 'Metabolism of vitamin K', 'Gamma carboxylation, hypusine formation and arylsulfatase activation', 'Hypusine synthesis from eIF5A-lysine', 'The activation of arylsulfatases', 'Gamma-carboxylation, transport, and amino-terminal cleavage of proteins', 'Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus', 'Removal of aminoterminal propeptides from gamma-carboxylated proteins', 'Gamma-carboxylation of protein precursors', 'Synthesis of diphthamide-EEF2', 'Pyrophosphate hydrolysis', 'Cytosolic iron-sulfur cluster assembly', 'Mitochondrial iron-sulfur cluster biogenesis', 'Electron transport from NADPH to Ferredoxin', 'Metabolism of proteins', 'Protein repair', 'Post-translational protein modification', 'Protein ubiquitination', 'E3 ubiquitin ligases ubiquitinate target proteins', 'Synthesis of active ubiquitin: roles of E1 and E2 enzymes', 'RAB geranylgeranylation', 'Protein methylation', 'SUMOylation', 'SUMO E3 ligases SUMOylate target proteins', 'SUMOylation of chromatin organization proteins', 'SUMOylation of DNA methylation proteins', 'SUMOylation of RNA binding proteins', 'SUMOylation of transcription factors', 'SUMOylation of intracellular receptors', 'SUMOylation of DNA damage response and repair proteins', 'SUMOylation of DNA replication proteins', 'SUMOylation of immune response proteins', 'SUMOylation of transcription cofactors', 'SUMOylation of ubiquitinylation proteins', 'SUMOylation of SUMOylation proteins', 'Processing and activation of SUMO', 'SUMO is transferred from E1 to E2 (UBE2I, UBC9)', 'SUMO is proteolytically processed', 'SUMO is conjugated to E1 (UBA2:SAE1)', 'Post-translational protein phosphorylation', 'Post-translational modification: synthesis of GPI-anchored proteins', 'Synthesis of glycosylphosphatidylinositol (GPI)', 'Attachment of GPI anchor to uPAR', 'Neddylation', 'Deubiquitination', 'Josephin domain DUBs', 'UCH proteinases', 'Metalloprotease DUBs', 'Ub-specific processing proteases', 'Ovarian tumor domain proteases', 'Carboxyterminal post-translational modifications of tubulin', 'Protein folding', 'Chaperonin-mediated protein folding', 'Association of TriC/CCT with target proteins during biosynthesis', 'Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding', 'Prefoldin mediated transfer of substrate  to CCT/TriC', 'Folding of actin by CCT/TriC', 'Formation of tubulin folding intermediates by CCT/TriC', 'Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding', 'Post-chaperonin tubulin folding pathway', 'Amyloid fiber formation', 'Unfolded Protein Response (UPR)', 'CREB3 factors activate genes', 'PERK regulates gene expression', 'ATF4 activates genes in response to endoplasmic reticulum  stress', 'IRE1alpha activates chaperones', 'XBP1(S) activates chaperone genes', 'ATF6 (ATF6-alpha) activates chaperones', 'ATF6 (ATF6-alpha) activates chaperone genes', 'Peptide hormone metabolism', 'Synthesis, secretion, and deacylation of Ghrelin', 'Peptide hormone biosynthesis', 'Glycoprotein hormones', 'Metabolism of Angiotensinogen to Angiotensins', 'Insulin processing', 'Incretin synthesis, secretion, and inactivation', 'Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)', 'Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)', 'Translation', 'SRP-dependent cotranslational protein targeting to membrane', 'Eukaryotic Translation Initiation', 'Cap-dependent Translation Initiation', 'Formation of a pool of free 40S subunits', 'GTP hydrolysis and joining of the 60S ribosomal subunit', 'Translation initiation complex formation', 'Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S', 'Ribosomal scanning and start codon recognition', 'Formation of the ternary complex, and subsequently, the 43S complex', 'Recycling of eIF2:GDP', 'L13a-mediated translational silencing of Ceruloplasmin expression', 'Eukaryotic Translation Elongation', 'Peptide chain elongation', 'tRNA Aminoacylation', 'Cytosolic tRNA aminoacylation', 'Mitochondrial tRNA aminoacylation', 'Eukaryotic Translation Termination', 'Mitochondrial translation', 'Mitochondrial translation elongation', 'Mitochondrial translation termination', 'Mitochondrial translation initiation', 'Metabolism of RNA', 'mRNA Editing', 'mRNA Editing: C to U Conversion', 'Formation of the Editosome', 'mRNA Editing: A to I Conversion', 'Formation of editosomes by ADAR proteins', 'C6 deamination of adenosine', 'Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA', 'tRNA processing', 'tRNA processing in the nucleus', 'tRNA processing in the mitochondrion', 'tRNA modification in the nucleus and cytosol', 'Synthesis of wybutosine at G37 of tRNA(Phe)', 'tRNA modification in the mitochondrion', 'Regulation of mRNA stability by proteins that bind AU-rich elements', 'Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA', 'Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA', 'KSRP (KHSRP) binds and destabilizes mRNA', 'AUF1 (hnRNP D0) binds and destabilizes mRNA', 'HuR (ELAVL1) binds and stabilizes mRNA', 'mRNA Capping', 'rRNA processing', 'rRNA processing in the nucleus and cytosol', 'rRNA modification in the nucleus and cytosol', 'Major pathway of rRNA processing in the nucleolus and cytosol', 'rRNA processing in the mitochondrion', 'rRNA modification in the mitochondrion', 'Processing of Capped Intron-Containing Pre-mRNA', "mRNA 3'-end processing", 'mRNA Splicing - Major Pathway', 'Transport of Mature Transcript to Cytoplasm', 'Transport of Mature mRNAs Derived from Intronless Transcripts', 'Transport of the SLBP independent Mature mRNA', 'Transport of the SLBP Dependant Mature mRNA', 'Transport of Mature mRNA Derived from an Intronless Transcript', 'Transport of Mature mRNA derived from an Intron-Containing Transcript', 'mRNA Splicing', 'mRNA Splicing - Minor Pathway', 'Processing of Capped Intronless Pre-mRNA', 'SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs', 'SLBP independent Processing of Histone Pre-mRNAs', 'Processing of Intronless Pre-mRNAs', 'Metabolism of non-coding RNA', 'snRNP Assembly', 'Muscle contraction', 'Smooth Muscle Contraction', 'Cardiac conduction', 'Ion homeostasis', 'Phase 4 - resting membrane potential', 'Phase 3 - rapid repolarisation', 'Phase 2 - plateau phase', 'Phase 1 - inactivation of fast Na+ channels', 'Phase 0 - rapid depolarisation', 'Physiological factors', 'Striated Muscle Contraction', 'Neuronal System', 'Transmission across Electrical Synapses ', 'Electric Transmission Across Gap Junctions', 'Potassium Channels', 'Inwardly rectifying K+ channels', 'Potassium transport channels', 'Classical Kir channels', 'G protein gated Potassium channels', 'Activation of G protein gated Potassium channels', 'ATP sensitive Potassium channels', 'Ca2+ activated K+ channels', 'Tandem pore domain potassium channels', 'TWIK-related alkaline pH activated K+ channel (TALK)', 'TWIK-related spinal cord K+ channel (TRESK)', 'Tandem pore domain halothane-inhibited K+ channel (THIK)', 'TWIK-releated acid-sensitive K+ channel (TASK)', 'TWIK related potassium channel (TREK)', 'Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)', 'Voltage gated Potassium channels', 'HCN channels', 'Organelle biogenesis and maintenance', 'Cilium Assembly', 'Anchoring of the basal body to the plasma membrane', 'Intraflagellar transport', 'Cargo trafficking to the periciliary membrane', 'VxPx cargo-targeting to cilium', 'ARL13B-mediated ciliary trafficking of INPP5E', 'BBSome-mediated cargo-targeting to cilium', 'Trafficking of myristoylated proteins to the cilium', 'Mitochondrial biogenesis', 'Transcriptional activation of mitochondrial biogenesis', 'Cristae formation', 'Activation of PPARGC1A (PGC-1alpha) by phosphorylation', 'Mitochondrial protein import', 'Programmed Cell Death', 'Protein localization', 'Peroxisomal protein import', 'TYSND1 cleaves peroxisomal proteins', 'Insertion of tail-anchored proteins into the endoplasmic reticulum membrane', 'Class I peroxisomal membrane protein import', 'Reproduction', 'Fertilization', 'Sperm Motility And Taxes', 'Interaction With Cumulus Cells And The Zona Pellucida', 'Acrosome Reaction and Sperm:Oocyte Membrane Binding', 'Signal Transduction', 'Intracellular signaling by second messengers', 'Signaling by Non-Receptor Tyrosine Kinases', 'MAPK family signaling cascades', 'MAPK6/MAPK4 signaling', 'Signaling by Rho GTPases', 'RHO GTPase Effectors', 'RHO GTPases regulate CFTR trafficking', 'RHO GTPases Activate Rhotekin and Rhophilins', 'Rho GTPase cycle', 'Signaling by WNT', 'Signaling by TGF-beta family members', 'Signaling by Activin', 'Antagonism of Activin by Follistatin', 'Signaling by GPCR', 'GPCR downstream signalling', 'GPCR ligand binding', 'Class C/3 (Metabotropic glutamate/pheromone receptors)', 'Class B/2 (Secretin family receptors)', 'Calcitonin-like ligand receptors', 'Glucagon-type ligand receptors', 'Signaling by Erythropoietin', 'Erythropoietin activates Phospholipase C gamma (PLCG)', 'Erythropoietin activates Phosphoinositide-3-kinase (PI3K)', 'Erythropoietin activates STAT5', 'Erythropoietin activates RAS', 'Signaling by Nuclear Receptors', 'ESR-mediated signaling', 'Estrogen-dependent gene expression', 'Signaling by Retinoic Acid', 'RA biosynthesis pathway', 'NR1H2 and NR1H3-mediated signaling', 'NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose', 'NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux', 'NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis', 'NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ', 'NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ', 'NR1H2 & NR1H3 regulate gene expression linked to lipogenesis', 'Signaling by Hedgehog', 'Signaling by Receptor Tyrosine Kinases', 'Signaling by MST1', 'Signaling by Leptin', 'Transport of small molecules', 'Aquaporin-mediated transport', 'Transport of glycerol from adipocytes to the liver by Aquaporins', 'Passive transport by Aquaporins', 'Mitochondrial calcium ion transport', 'Processing of SMDT1', 'O2/CO2 exchange in erythrocytes', 'Erythrocytes take up oxygen and release carbon dioxide', 'SLC-mediated transmembrane transport', 'Miscellaneous transport and binding events', 'Intracellular oxygen transport', 'Ion channel transport', 'Stimuli-sensing channels', 'TRP channels', 'Ion transport by P-type ATPases', 'Vesicle-mediated transport', 'Membrane Trafficking', 'Gap junction trafficking and regulation', 'Regulation of gap junction activity', 'Gap junction trafficking', 'Gap junction degradation', 'Formation of annular gap junctions', 'Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane', 'Transport of connexons to the plasma membrane', 'Oligomerization of connexins into connexons', 'Gap junction assembly', 'Transport of connexins along the secretory pathway', 'Rab regulation of trafficking', 'RAB GEFs exchange GTP for GDP on RABs', 'TBC/RABGAPs', 'Intra-Golgi and retrograde Golgi-to-ER traffic', 'Retrograde transport at the Trans-Golgi-Network', 'Golgi-to-ER retrograde transport', 'COPI-independent Golgi-to-ER retrograde traffic', 'COPI-dependent Golgi-to-ER retrograde traffic', 'Intra-Golgi traffic', 'Translocation of SLC2A4 (GLUT4) to the plasma membrane', 'trans-Golgi Network Vesicle Budding', 'Golgi Associated Vesicle Biogenesis', 'Lysosome Vesicle Biogenesis', 'Clathrin-mediated endocytosis', 'Cargo recognition for clathrin-mediated endocytosis', 'Endosomal Sorting Complex Required For Transport (ESCRT)', 'Binding and Uptake of Ligands by Scavenger Receptors', 'Scavenging of heme from plasma', 'Scavenging by Class F Receptors', 'Scavenging by Class B Receptors', 'Scavenging by Class H Receptors', 'Scavenging by Class A Receptors']